US equities
|
TSLA
$394.23
▲+5.91%
MU
$907.81
▲+3.45%
SPCX
$149.28
▲+1.21%
NVDA
$215.78
▲+2.28%
META
$641.04
▼-0.25%
SNDK
$1,268.59
▲+2.47%
AAPL
$344.93
▼-0.80%
INTC
$90.71
▲+4.31%
TSLA
$394.23
▲+5.91%
MU
$907.81
▲+3.45%
SPCX
$149.28
▲+1.21%
NVDA
$215.78
▲+2.28%
META
$641.04
▼-0.25%
SNDK
$1,268.59
▲+2.47%
AAPL
$344.93
▼-0.80%
INTC
$90.71
▲+4.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
(OP:
BORAY
)
2.450
UNCHANGED
Last Price
Updated: 2:23 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BORAY
Bora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO Tablets
July 23, 2026
From
Bora Pharmaceuticals Co., Ltd.
Via
Business Wire
Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations
July 02, 2026
TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced...
Via
MediaOutReach
Topics
Economy
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Bora Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12th
March 03, 2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at...
From
Virtual Investor Conferences
Via
GlobeNewswire
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
February 23, 2026
From
Bora Pharmaceuticals Co., Ltd.
Via
Business Wire